Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > December 19, 2023
Daily News
December 19, 2023
- Women’s Health Drugs on a Roll, Further Growth Expected as Public Awareness Rises
December 19, 2023
- DyDo Pharma Files Its 1st Drug, LEMS Treatment for Japan Market
December 19, 2023
- EMA Endorses GHIT-Funded Schistosomiasis Therapy
December 19, 2023
- Dupixent 200 mg Syringe Now Available in Japan: Sanofi
December 19, 2023
- Shionogi, Sobi Ink Fetcroja Distribution Pact for 13 European Countries
December 19, 2023
- Shionogi Kicks Off PIII Booster Trial for XBB1.5 COVID Vaccine in Japan
December 19, 2023
- Takeda’s Hyqvia Gets EU Panel Backing for CIDP Maintenance Therapy
December 19, 2023
- Padcev/Keytruda Combo Nabs FDA Nod for 1st Line Bladder Cancer
December 19, 2023
- Eisai Files Tasurgratinib for Biliary Tract Cancer in Japan
December 19, 2023
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Recent trends are creating a fascinating push-and-pull effect in the talent market. We’re seeing more positions opening up, but also a greater number of candidates available, particularly in the fields of rare diseases and oncology. This “more positions, more candidates”…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…